Predict your next investment

COMPUTER HARDWARE & SERVICES | Computer Product Distribution & Support Services
axcessinc.com

See what CB Insights has to offer

Founded Year

1981

Stage

Unattributed VC - II | Alive

Total Raised

$3.05M

Last Raised

$750K | 15 yrs ago

About AXCESS International

AXCESS International is a Computer Hardware & Services/Computer Product Distribution & Support Services company based in Addison, Texas. AXCESS International has received investment from Amphion Innovations PLC..

AXCESS International Headquarter Location

16650 Westgrove Drive Suite 600

Addison, Texas, 75001,

United States

972-407-6080

Latest AXCESS International News

Biometrics integrator Genetec vanquishes patent troll, receives payment

Aug 12, 2020

Aug 12, 2020 Genetec , which integrates biometric technologies from a range of partners, has defeated a non-performing entity, otherwise known as a patent troll, and been paid an undisclosed sum to conclude the proceedings, the company announced. Axcess International filed a suit against Genetec  in August of 2018, alleging the access control vendor violated its patent for a “Method and system for providing integrated remote monitoring services.” The patent describes the integration of RFID and video data. The complaint was withdrawn early in the process, and Axcess International paid to resolve the case, a highly unusual result, according to the announcement. Patent trolls were involved in 90 percent of high-tech patent litigation cases in 2019, Genetec says, citing a Unified Patents report. “Unlike the way many other companies deal with these sorts of attacks, we do not negotiate payment with patent trolls,” states Pierre Racz, president of Genetec Inc. “Despite the potentially high cost of litigation, bending to their anti-innovation tactics only encourages their behavior and, as a matter of principle, Genetec will always vigorously defend its technology and the hard work of the people who create it. Though we have quietly followed this course since the first patent troll arrived at our door, we felt that this occasion was a good time to speak out against this practice.” “This represents an important symbolic victory for Genetec, and a clear demonstration of our policy of never paying nuisance value settlements,” Genetec Director of Intellectual Property Jean-Yves Pikulik comments. “While we would much rather spend our time patenting our innovations than fighting off patent trolls, we will continue to vigorously defend ourselves against NPEs and seek legal costs in lawsuits that we perceive as frivolous.” Axcess International had also filed the same complaint against ACTi Corp, Foxconn International, UTC Fire & Security Americas Corporation and Lenel Systems International, and Bosch Security Systems. Genetec is partnered with many biometrics providers, such as NtechLab , EyeLock  and AnyVision .

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

AXCESS International Patents

AXCESS International has filed 11 patents.

patents chart

Application Date

Grant Date

Title

Related Topics

Status

3/8/2012

6/5/2018

Progestogens, Androgens and anabolic steroids, Fluoroarenes, Ketones, Prodrugs

Grant

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Application Date

3/8/2012

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Grant Date

6/5/2018

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Title

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Related Topics

Progestogens, Androgens and anabolic steroids, Fluoroarenes, Ketones, Prodrugs

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Grant

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.